Gufic Biosciences (NSE:GUFICBIO) Total Liabilities : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Gufic Biosciences Total Liabilities?

Gufic Biosciences's Total Liabilities for the quarter that ended in Dec. 2024 was ₹0 Mil.

Gufic Biosciences's quarterly Total Liabilities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹5,304.90 Mil) but then declined from Sep. 2024 (₹5,304.90 Mil) to Dec. 2024 (₹0.00 Mil).

Gufic Biosciences's annual Total Liabilities increased from Mar. 2022 (₹2,522.84 Mil) to Mar. 2023 (₹5,133.51 Mil) and increased from Mar. 2023 (₹5,133.51 Mil) to Mar. 2024 (₹5,599.81 Mil).

Gufic Biosciences Total Liabilities Historical Data

The historical data trend for Gufic Biosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gufic Biosciences Total Liabilities Chart

Gufic Biosciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

2,781.95

2,186.24

2,522.84

5,133.51

5,599.81

Gufic Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															-	5,599.81	-	5,304.90	-

Gufic Biosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Gufic Biosciences's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3720.489	+	(1655.182	+	224.138
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	5,600

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	10925.414	-	5325.605
	=	5,600

Gufic Biosciences's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	N/A	-	N/A
	=	N/A

Gufic Biosciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Gufic Biosciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Gufic Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gufic Biosciences Ltd (NSE:GUFICBIO) » Definitions » Total Liabilities

Traded in Other Exchanges

509079:India

Address

SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057

Website

https://www.gufic.com

Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare; Criticare Life; Ferticare; Spark; Herbal and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral and a proton-pump inhibitor. It derives maximum revenue from India.

Gufic Biosciences Headlines

No Headlines